Revlimid developed by Celgene Corp. is intended for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1?risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
Multiple Myeloma Revlimid
Revlimid in combination with dexamethasone is used for the treatment of multiple myeloma patients who have received at least one prior therapy. The FDA approved Revlimid fo...
| Currently you cannot purchase Revlimeed as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Revlimeed |
| Revlimeed Availability Subscription Form |
|
| |
| Note: We will email you when Revlimeed is available for sale online or in pharmacy in your country. |
|
|
|